Suppr超能文献

影响巴西副球孢子菌病治疗依从性的因素。

Factors influencing treatment adherence in paracoccidioidomycosis in Brazil.

作者信息

Kruschewsky Wdson Luis Lima, Dal Col Batista Ricardo, Oliveira Hosana Ewald, Falqueto Aloísio, Peçanha Paulo Mendes, Grão Velloso Tânia Regina, Tavares Sarah Gonçalves, Vicente Creuza Rachel

机构信息

Faculdade de Medicina, Universidade Federal do Espírito Santo Vitória Brazil.

Programa de Pós-Graduação em Doenças Infecciosas, Universidade Federal do Espírito Santo Vitória Brazil.

出版信息

Public Health Chall. 2023 Jan 11;2(1):e49. doi: 10.1002/puh2.49. eCollection 2023 Mar.

Abstract

INTRODUCTION

Paracoccidioidomycosis is a systemic mycosis endemic to Latin America, with frequent reports of poor treatment adherence resulting in worse clinical outcomes. The present study evaluated factors related to treatment adherence in patients with paracoccidioidomycosis.

METHODS

This cross-sectional study included data from medical records of patients with paracoccidioidomycosis treated between 2005 and 2018 in a reference hospital in southeastern Brazil. Clinical variables, demographic characteristics, and smoking and alcohol consumption were collected and analyzed.

RESULTS

Of the 198 cases included, most were adults (median age = 51 years), males (93.4%), presented chronic paracoccidioidomycosis (83.8%), reported smoking (90.4%) and alcohol consumption (84.8%), and 56.6% adhered to treatment. Treatment adherence was associated with the discontinuation of alcohol consumption (odds ratios (OR) = 5.227; 95% confidence interval (CI) = 2.697-10.129) and smoking (OR = 3.365; 95% CI = 1.781-6.358) during therapy.

CONCLUSIONS

Patients' continued consumption of alcohol and tobacco was associated with non-adherence to treatment, suggesting that a joint therapeutic approach that addresses alcohol and tobacco use alongside paracoccidioidomycosis treatment may hold promise for improving adherence and patients' quality of life.

摘要

引言

副球孢子菌病是一种拉丁美洲特有的系统性真菌病,经常有报道称治疗依从性差会导致更差的临床结果。本研究评估了与副球孢子菌病患者治疗依从性相关的因素。

方法

这项横断面研究纳入了2005年至2018年在巴西东南部一家参考医院接受治疗的副球孢子菌病患者的病历数据。收集并分析了临床变量、人口统计学特征以及吸烟和饮酒情况。

结果

在纳入的198例病例中,大多数为成年人(中位年龄 = 51岁),男性(93.4%),患有慢性副球孢子菌病(83.8%),报告有吸烟(90.4%)和饮酒(84.8%),56.6%的患者坚持治疗。治疗依从性与治疗期间戒酒(比值比(OR)= 5.227;95%置信区间(CI)= 2.697 - 10.129)和戒烟(OR = 3.365;95% CI = 1.781 - 6.358)有关。

结论

患者持续饮酒和吸烟与治疗不依从有关,这表明在治疗副球孢子菌病的同时解决饮酒和吸烟问题的联合治疗方法可能有望提高依从性和患者的生活质量。

相似文献

1
Factors influencing treatment adherence in paracoccidioidomycosis in Brazil.
Public Health Chall. 2023 Jan 11;2(1):e49. doi: 10.1002/puh2.49. eCollection 2023 Mar.
2
[Association between smoking and paracoccidioidomycosis: a case-control study in the State of Espírito Santo, Brazil].
Cad Saude Publica. 2003 Jan-Feb;19(1):245-53. doi: 10.1590/s0102-311x2003000100027. Epub 2003 Apr 1.
3
Oral paracoccidioidomycosis in a single-center retrospective analysis from a Brazilian southeastern population.
J Infect Public Health. 2018 Jul-Aug;11(4):530-533. doi: 10.1016/j.jiph.2017.10.009. Epub 2017 Nov 16.
4
Head and neck manifestations of paracoccidioidomycosis: an epidemiological study of 36 cases in Brazil.
Mycopathologia. 2012 Mar;173(2-3):139-44. doi: 10.1007/s11046-011-9488-5. Epub 2011 Oct 12.
5
Acute juvenile Paracoccidioidomycosis: A 9-year cohort study in the endemic area of Rio de Janeiro, Brazil.
PLoS Negl Trop Dis. 2017 Mar 29;11(3):e0005500. doi: 10.1371/journal.pntd.0005500. eCollection 2017 Mar.
6
[Paracoccidioidomycosis in Brazilian Indians of the Suruí tribe: clinical-laboratory study of 2 cases].
Rev Soc Bras Med Trop. 1999 Sep-Oct;32(5):571-5. doi: 10.1590/s0037-86821999000500015.
7
Spontaneous pneumothorax in paracoccidioidomycosis patients from an endemic area in Midwestern Brazil.
Mycoses. 2017 Feb;60(2):124-128. doi: 10.1111/myc.12571. Epub 2016 Sep 30.
8
Treatment compliance of patients with paracoccidioidomycosis in Central-West Brazil.
J Bras Pneumol. 2019 Apr 18;45(2):e20180167. doi: 10.1590/1806-3713/e20180167.
9
Endemic paracoccidioidomycosis: relationship between clinical presentation and patients' demographic features.
Med Mycol. 2013 Apr;51(3):313-8. doi: 10.3109/13693786.2012.714529. Epub 2012 Aug 28.
10
New Trends in Paracoccidioidomycosis Epidemiology.
J Fungi (Basel). 2017 Jan 3;3(1):1. doi: 10.3390/jof3010001.

本文引用的文献

1
New Insights on Pulmonary Paracoccidioidomycosis.
Semin Respir Crit Care Med. 2020 Feb;41(1):53-68. doi: 10.1055/s-0039-3400544. Epub 2020 Jan 30.
2
Oral paracoccidioidomycosis in a single-center retrospective analysis from a Brazilian southeastern population.
J Infect Public Health. 2018 Jul-Aug;11(4):530-533. doi: 10.1016/j.jiph.2017.10.009. Epub 2017 Nov 16.
3
Paracoccidioidomycosis: Epidemiological and Clinical Aspects in 546 Cases Studied in the State of Espírito Santo, Brazil.
Am J Trop Med Hyg. 2017 Sep;97(3):836-844. doi: 10.4269/ajtmh.16-0790. Epub 2017 Jul 27.
4
Brazilian guidelines for the clinical management of paracoccidioidomycosis.
Rev Soc Bras Med Trop. 2017 Sep-Oct;50(5):715-740. doi: 10.1590/0037-8682-0230-2017. Epub 2017 Jul 12.
5
Species boundaries in the human pathogen Paracoccidioides.
Fungal Genet Biol. 2017 Sep;106:9-25. doi: 10.1016/j.fgb.2017.05.007. Epub 2017 Jun 9.
6
PARACOCCIDIOIDOMYCOSIS TREATMENT.
Rev Inst Med Trop Sao Paulo. 2015 Sep;57 Suppl 19(Suppl 19):31-7. doi: 10.1590/S0036-46652015000700007.
7
Comparison between itraconazole and cotrimoxazole in the treatment of paracoccidiodomycosis.
PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2793. doi: 10.1371/journal.pntd.0002793. eCollection 2014 Apr.
8
Endemic paracoccidioidomycosis: relationship between clinical presentation and patients' demographic features.
Med Mycol. 2013 Apr;51(3):313-8. doi: 10.3109/13693786.2012.714529. Epub 2012 Aug 28.
9
Hormones and the resistance of women to paracoccidioidomycosis.
Clin Microbiol Rev. 2011 Apr;24(2):296-313. doi: 10.1128/CMR.00062-10.
10
[Paracoccidioidomycosis at Brasilias university hospital].
Rev Soc Bras Med Trop. 2008 Mar-Apr;41(2):169-72. doi: 10.1590/s0037-86822008000200007.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验